Henry Schein Shares Slip After Q1 Call Highlights Dental Gains, Medical Weakness

Henry Schein Inc. (HSIC) shares traded at $68.99 after its first-quarter earnings call, down from $72.02 before the results, as investors weighed strong U.S. dental and global technology growth against weakness in medical diagnostics demand. CEO Frederick Lowery said the company benefited from dental market share gains, stable procedure volumes, merchandise price increases and continued investment by dental service organizations. Growth in Home Solutions and technology offerings helped offset lower demand for point-of-care diagnostic products, which the company attributed to a lighter flu season. Key investor focus areas for upcoming quarters include adoption of AI-powered and cloud-based dental software, progress on cost savings and value creation initiatives weighted toward the second half of 2026, and recovery in medical segment sales outside point-of-care diagnostics. Execution in proprietary brands and digital offerings remains central to margin improvement.